• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.

作者信息

Gregersen Ida, Ueland Thor, Holter Jan Cato, Olsen Maria Belland, Michelsen Annika E, Murphy Sarah L, Tveita Anders Aune, Henriksen Katerina Nezvalova, Hoel Hedda, Nordberg Lena Bugge, Holten Aleksander Rygh, Edvardsen Thor, Yang Kuan, Heggelund Lars, Trøseid Marius, Müller Fredrik, Kildal Anders Benjamin, Dyrhol-Riise Anne Ma, Barratt-Due Andreas, Dahl Tuva B, Aukrust Pål, Halvorsen Bente

机构信息

Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway.

Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.

出版信息

J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.09.029. Epub 2022 Oct 8.

DOI:10.1016/j.jinf.2022.09.029
PMID:36216188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9546500/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8549/9546500/65d5156909c9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8549/9546500/65d5156909c9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8549/9546500/65d5156909c9/gr1_lrg.jpg

相似文献

1
CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.CXCL16与新冠病毒病住院患者的不良预后及心脏受累相关。
J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.09.029. Epub 2022 Oct 8.
2
Elevated plasma levels of CXCL16 in severe COVID-19 patients.严重 COVID-19 患者血浆中 CXCL16 水平升高。
Cytokine. 2022 Apr;152:155810. doi: 10.1016/j.cyto.2022.155810. Epub 2022 Jan 31.
3
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.新型冠状病毒 2 型在年轻竞技运动员心脏中的作用。
Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17.
4
Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.心脏 SARS-CoV-2 感染与心脏内促炎转录组改变有关。
Cardiovasc Res. 2022 Jan 29;118(2):542-555. doi: 10.1093/cvr/cvab322.
5
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.心脏感染与确诊 COVID-19 尸检病例中 SARS-CoV-2 的关联。
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285. doi: 10.1001/jamacardio.2020.3551.
6
IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.白细胞介素-22在COVID-19住院患者中升高，并与心脏受累相关。
J Infect. 2024 Jul;89(1):106176. doi: 10.1016/j.jinf.2024.106176. Epub 2024 May 6.
7
Cxcl16 interact with SARS-CoV N protein in and out cell.Cxcl16 与 SARS-CoV N 蛋白在细胞内外相互作用。
Virol Sin. 2010 Oct;25(5):369-74. doi: 10.1007/s12250-010-3129-x. Epub 2010 Oct 8.
8
Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.与 COVID-19 相关的神经精神症状儿童的脑脊液细胞因子、趋化因子和 SARS-CoV-2 抗体特征。
Mult Scler Relat Disord. 2021 Oct;55:103169. doi: 10.1016/j.msard.2021.103169. Epub 2021 Jul 24.
9
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.新冠病毒感染住院患者及新冠病毒感染后急性后遗症患者神经病理发生的血浆生物标志物
Neurol Neuroimmunol Neuroinflamm. 2022 Mar 7;9(3). doi: 10.1212/NXI.0000000000001151. Print 2022 May.
10
Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.评价跨膜趋化因子 CXCL16 和 CX3CL1、其受体以及它们的加工金属蛋白酶 ADAM10 和 ADAM17 在增殖性糖尿病视网膜病变中的蛋白形式。
Front Immunol. 2021 Jan 20;11:601639. doi: 10.3389/fimmu.2020.601639. eCollection 2020.

引用本文的文献

1
sCXCL16 as a prognostic biomarker for COVID-19 outcome.sCXCL16 作为 COVID-19 预后的生物标志物。
J Med Virol. 2023 Apr;95(4):e28728. doi: 10.1002/jmv.28728.